AKG‑Driven Epigenetic Reprogramming of Senescent Cells Shifts SASP From Chronic Inflammation to Transient Tissue Repair
Hypothesis
Alpha‑ketoglutarate (AKG) reprograms persistently senescent cells into a transient, repair‑promoting state by shifting the composition of their senescence‑associated secretory phenotype (SASP) from pro‑inflammatory to pro‑regenerative through TET‑dependent DNA demethylation of key enhancer elements.
Mechanistic Basis
AKG serves as a cofactor for ten‑eleven translocation (TET) dioxygenases, which oxidize 5‑methylcytosine to 5‑hydroxymethylcytosine and initiate DNA demethylation [6]. In senescent cells, chronic inflammation is driven by NF‑κB‑dependent transcription of IL6, IL8 and other SASP factors, whereas transient senescence during wound repair relies on PDGFAA, VEGF and matrix‑remodeling enzymes such as MMP14 [1][2]. We propose that AKG‑enhanced TET activity preferentially demethylates enhancers upstream of PDGFA and MMP14, increasing their accessibility to transcription factors like AP‑1 and TEAD, while simultaneously promoting methylation or hydroxymethylation at NF‑κB binding sites in the IL6 promoter, reducing its activity. This epigenetic rewiring would convert a chronic SASP into a transient, tissue‑repairing signature without eliminating the senescent cell itself.
Predictions and Experimental Design
- SASP shift – Human fibroblasts rendered senescent by irradiation will show decreased IL6 and IL8 secretion and increased PDGFAA and MMP14 release after 48 h AKG (2 mM) treatment, measured by ELISA and proteomics.
- Epigenetic marks – Bisulfite‑sequencing and oxidative bisulfite‑sequencing will reveal reduced 5‑mC and increased 5‑hmC at the PDGFA and MMP14 enhancers, and increased 5‑mC (or decreased 5‑hmC) at the IL6 promoter CpG islands in AKG‑treated senescent cells.
- TET dependence – CRISPR‑KO of TET2 in senescent fibroblasts will abolish the AKG‑induced SASP shift, confirming mechanistic reliance on TET activity.
- Functional read‑out – In a full‑thickness excisional wound model in aged mice, topical AKG will accelerate closure and reduce fibrosis compared with vehicle, while senolytic treatment will impair early granulation tissue formation. Immunostaining for p16 will show persistent senescent cells in AKG wounds that co‑express PDGFAA, indicating a reparative SASP.
Potential Implications
If validated, this hypothesis repositions senescent cells as epigenetically plastic conduits that can be steered toward beneficial functions rather than eradicated. It suggests that AKG supplementation, or other TET‑activating metabolites, could uncouple the deleterious chronic SASP from the essential transient senescence program, preserving tissue‑remodeling chaperones while mitigating age‑related pathology.